Form 4 AGNT, Inc. For: Oct 12 Filed by: Pareja Leonardo
http://archive.fast-edgar.com/20261013/ARBZM22CZ222R222222922Z2QKSNZK22B582
Filed on: October 13, 2026
Form 8-K Grayscale Bittensor Trus For: Oct 07
http://archive.fast-edgar.com/20261013/AE22C22GZM2R39Z222292ZYJGBTDEZ223282
Filed on: October 13, 2026
Form 8-K ACCURAY INC For: Oct 08
http://archive.fast-edgar.com/20261013/AUZZB22CZW22SJZ2222L2ZZZAMMGZ6V8QK82
Filed on: October 13, 2026
Form 4 WILLIS TOWERS WATSON For: Oct 09 Filed by: Kurpis Joseph Stephen
http://archive.fast-edgar.com/20261013/AQ2W322CZ222E2Z222292M4W883HZE223282
Filed on: October 13, 2026
Form 8-A12B CITY THERAPEUTICS, INC.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
City Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 93-2762122 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) ... (continue reading...)
More SEC Filings
View Older Stories-
Form ARS Marathon Bancorp, Inc. For: Jun 30
-
Form DEFA14A EGAIN Corp
-
Form 144 ETSY INC Filed by: Silverman Josh
-
Form 144 BETA Technologies, Inc. Filed by: Clark Kyle
-
Form 4 WILLIS TOWERS WATSON For: Oct 09 Filed by: Pullum Anne
-
Form 144 AMKOR TECHNOLOGY, INC. Filed by: Faust Megan
-
Form N-8A Nuveen Enhanced Strategi
-
Form DEFA14A Senti Biosciences Holdin
-
Form 144 Everpure, Inc. Filed by: Singh Ajay
-
Form S-1 EuroSPAC Acquisition
-
Form 144 IDT CORP Filed by: SILBERMAN MITCH
-
Form 10-K OKMIN RESOURCES, INC. For: Jun 30
-
Form S-8 Alibaba Group Holding
-
Form 6-K DAQO NEW ENERGY CORP. For: Oct 13
-
Form DEF 14A Marathon Bancorp, Inc. For: Nov 17
-
Form 4 WILLIS TOWERS WATSON For: Oct 09 Filed by: Qureshi Imran Ahmed
-
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.
-
Form 8-K Senti Biosciences Holdin For: Oct 08
-
Form 6-K Nano Labs Ltd For: Oct 13
-
Form 4 QumulusAI, Inc. For: Oct 09 Filed by: Bissell Robert Christopher
-
Form D/A Mojo Ventures Fund I,
-
Form SCHEDULE 13G Knight-Swift Transportat Filed by: PointState Capital LP
-
Form 8-K/A Tarsus Pharmaceuticals, For: Sep 04
-
Form 6-K TOWER SEMICONDUCTOR LTD For: Oct 13
-
Form PRE 14A JOHN HANCOCK VARIABLE For: Jan 05
-
Form 8-K NEPHROS INC For: Oct 13
-
Form 4 Credo Technology Group For: Oct 08 Filed by: Fleming Daniel W.
-
Form DEFA14A Strategy Inc
-
Form 10-K ESCALON MEDICAL CORP For: Jun 30
-
Form 6-K MATERIALISE NV For: Oct 13
-
Form 144 PINTEREST, INC. Filed by: Silbermann Benjamin
-
Form DEF 14A EGAIN Corp For: Dec 04
-
Form 4 CYTOKINETICS INC For: Oct 12 Filed by: Blum Robert I
-
Form 8-K Niki BioSolutions, Inc. For: Oct 13
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 Strategy Inc For: Oct 08 Filed by: Patten Jarrod M
-
Form 8-A12B Iambic Therapeutics,
-
Form 424B2 HSBC USA INC /MD/
-
Form FWP BARCLAYS BANK PLC Filed by: BARCLAYS BANK PLC
-
Form 424B2 HSBC USA INC /MD/
-
Form 13F-HR 4WEALTH ADVISORS, INC. For: Sep 30
-
Form D Dvant Pharma, Inc.
-
Form D/A Blue Impact Fund II, LP
-
Form 424B2 WELLS FARGO & COMPANY/MN
-
Form 424B2 HSBC USA INC /MD/
-
Form 424B2 HSBC USA INC /MD/
-
Form 424B2 HSBC USA INC /MD/
-
Form 424B2 WELLS FARGO & COMPANY/MN
-
Form D Praxis Tech, Inc.
